More than 100 million patients trust our products.
About 50% of the Zentiva team works in our Industrial Operations to ensure the supply of high quality affordable medicines.
Zentiva has four wholly-owned manufacturing sites:
- Prague Site in the Czech Republic is operating for more than 90 years
- Bucharest Site 1, in Romania, is operating for more than 60 years
- Bucharest Site 2, in Romania, acquired in 2020
- Ankleshwar Site, in India, was acquired in 2020
Our sites manufacture more than 70% of Zentiva’s product supply, the balance coming from our network of more than 250 supply partners.
All Sites are driving Sustainability programmes, targeting carbon neutrality for Scope 1 and Scope 2 by 2030 and constantly strengthening their efficiency when it comes to energy, electricity, water consumption and waste management.
Zentiva's focus on sustainability
All Sites are driving Sustainability programs, targeting carbon neutrality for Scope 1 and Scope 2 by 2030 and constantly strengthening their efficiency when it comes to energy and electricity, water consumption and waste management. While the European manufacturing sites are already sourced by 100% renewable energy, we are reaching 60% for our Ankleshwar site in India, and looking for options to further increase this share.
The Zentiva manufacturing sites combine well with our manufacturing and supply partnerships to produce competitive cost of goods that supports our performance across the three key market archetypes of Europe. This is key in the three key market archetypes of Europe – Physician Driven, Pharmacy Driven and Key Accounts/Tender Driven. We operate a highly flexible manufacturing footprint and are well positioned to continue to improve our customer service level across the supply chain operation. We have ensured the right level of capital investment across our network supporting us in accommodating the volume growth in our mid-term plan.